SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Ghatnekar Ola)
 

Search: WFRF:(Ghatnekar Ola) > (2006) > Estimating the valu...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Hjelmgren, Jonas (author)

Estimating the value of novel interventions for Parkinson's disease: An early decision-making model with application to dopamine cell replacement.

  • Article/chapterEnglish2006

Publisher, publication year, extent ...

  • Elsevier BV,2006
  • electronicrdacarrier

Numbers

  • LIBRIS-ID:oai:lup.lub.lu.se:f26aa2f5-4379-4568-a9ad-b687457477ad
  • https://lup.lub.lu.se/record/158123URI
  • https://doi.org/10.1016/j.parkreldis.2006.04.006DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:art swepub-publicationtype
  • Subject category:ref swepub-contenttype

Notes

  • A long-term cost-effectiveness model for early decision-making and estimation of outcomes of novel therapeutic procedures for Parkinson's disease (PD) was developed based on the Hoehn and Yahr (HY) stages of PD. Results provided support for model validity. Model application to a future dopamine cell replacement therapy indicated long-term cost offsets and gains in quality-adjusted life years (QALYs) in early onset PD (HY III-IV), as compared to standard drug therapy. The maximum price premium (i.e., profit or compensation for developmental costs) for the intervention to remain cost-effective was estimated to EURO12000-64000 according to cost-per-QALY thresholds of EURO38000-70000 and depending on whether all or only medical direct costs are considered. The study illustrates the value of early health economic modeling and the described model shows promise as a means to estimate outcomes and aid decision-making regarding novel interventions for PD. (c) 2006 Elsevier Ltd. All rights reserved.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Ghatnekar, Ola (author)
  • Reimer, JanLund University,Lunds universitet,Wallenberg Neurocentrum, Lund,Medicinska fakulteten,Wallenberg Neuroscience Centre, Lund,Faculty of Medicine(Swepub:lu)neur-jre (author)
  • Grabowski, MartinLund University,Lunds universitet,Neurologi, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Neurology, Lund,Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)neur-mgr (author)
  • Lindvall, OlleLund University,Lunds universitet,Wallenberg Neurocentrum, Lund,Medicinska fakulteten,Wallenberg Neuroscience Centre, Lund,Faculty of Medicine(Swepub:lu)neur-oli (author)
  • Persson, Ulf (author)
  • Hagell, PeterLund University,Lunds universitet,Institutionen för hälsovetenskaper,Medicinska fakulteten,Department of Health Sciences,Faculty of Medicine(Swepub:lu)neur-pha (author)
  • Wallenberg Neurocentrum, LundMedicinska fakulteten (creator_code:org_t)

Related titles

  • In:Parkinsonism & Related Disorders: Elsevier BV12:7, s. 443-4521873-51261353-8020

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view